These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15244111)

  • 61. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
    François J; Koning E; Ferrandon A; Nehlig A
    Epilepsy Res; 2006 Dec; 72(2-3):147-63. PubMed ID: 16945504
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Weight loss with topiramate in patients with epileptic disorders].
    Carnero Fernández M; Morales Gorría MJ; Corredera García E; Del Campo Pérez V
    Med Clin (Barc); 2005 Apr; 124(16):636-7. PubMed ID: 15871784
    [No Abstract]   [Full Text] [Related]  

  • 63. Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca(2+)-induced Ca(2+)-releasing systems.
    Okada M; Yoshida S; Zhu G; Hirose S; Kaneko S
    Neuroscience; 2005; 134(1):233-46. PubMed ID: 15961239
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of topiramate on glucocorticoid receptor mediated action.
    Yehuda R; Yang RK; Golier JA; Tischler L; Liong B; Decker K
    Neuropsychopharmacology; 2004 Feb; 29(2):433-9. PubMed ID: 14666121
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic Option.
    Siniscalchi A; Bonci A; Biagio Mercuri N; Pirritano D; Squillace A; De Sarro G; Gallelli L
    Curr Neuropharmacol; 2015; 13(6):815-8. PubMed ID: 26630959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Topiramate: pharmacokinetics and pharmacodynamics.
    Schneiderman JH
    Can J Neurol Sci; 1998 Aug; 25(3):S3-5. PubMed ID: 9706732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication.
    Drapalski AL; Rosse RB; Peebles RR; Schwartz BL; Marvel CL; Deutsch SI
    Clin Neuropharmacol; 2001; 24(5):290-4. PubMed ID: 11586114
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of topiramate on seizure susceptibility in kainate-kindled rats: involvement of peripheral-type benzodiazepine receptors.
    Chen C; Lang S; Xu G; Liu X; Zuo P
    Seizure; 2008 Jun; 17(4):358-63. PubMed ID: 18164215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacology and clinical results of topiramate (TOPINA Tablets), a new antiepileptic drug].
    Kobayashi M; Watanabe M; Nakamura J
    Nihon Yakurigaku Zasshi; 2008 Jul; 132(1):45-52. PubMed ID: 18622103
    [No Abstract]   [Full Text] [Related]  

  • 71. Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury.
    Gensel JC; Tovar CA; Bresnahan JC; Beattie MS
    PLoS One; 2012; 7(3):e33519. PubMed ID: 22428066
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative EEG effects of topiramate.
    Wang WW; Li JC; Wu X
    Clin Electroencephalogr; 2003 Apr; 34(2):87-92. PubMed ID: 12784907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Topiramate in the treatment of cluster headache.
    McGeeney BE
    Curr Pain Headache Rep; 2003 Apr; 7(2):135-8. PubMed ID: 12628055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Topiramate has protective effect on renal injury.
    Cure MC; Cure E; Tumkaya L; Kalkan Y; Aydin I; Kirbas A; Efe H; Sehitoglu I; Yuce S
    Bratisl Lek Listy; 2015; 116(4):259-63. PubMed ID: 25773955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacology of AMPA antagonists and their role in neuroprotection.
    Gill R; Lodge D
    Int Rev Neurobiol; 1997; 40():197-232. PubMed ID: 8989622
    [No Abstract]   [Full Text] [Related]  

  • 76. [Challenges in epilepsy therapy: start low, go slow. 72nd Congress of the German Society for Neurology. Topiramate--a valuable new tool for the therapy of focal epilepsy? 1 October 1999, Magdeburg].
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12 Suppl Herausford):1-4. PubMed ID: 10686677
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of paraphilic sexual disorder: the use of topiramate in fetishism.
    Shiah IS; Chao CY; Mao WC; Chuang YJ
    Int Clin Psychopharmacol; 2006 Jul; 21(4):241-3. PubMed ID: 16687996
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protective effects of forced exercise against topiramate-induced cognition impairment and enhancement of its antiepileptic activity: molecular and behavioral evidences.
    Soleimani Meigoni Z; Jabari F; Motaghinejad M; Motevalian M
    Int J Neurosci; 2022 Dec; 132(12):1198-1209. PubMed ID: 33428483
    [No Abstract]   [Full Text] [Related]  

  • 79. Spinal myoclonus responsive to topiramate.
    Siniscalchi A; Mancuso F; Russo E; Ibbadu GF; De Sarro G
    Mov Disord; 2004 Nov; 19(11):1380-1. PubMed ID: 15389982
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The utility of the lh/lh mutant mouse as a animal model of human absence epilepsy.
    Kamin M; Cazzaniga EK; Raina MK; Shank RP
    Epilepsia; 1998 Feb; 39(2):232-3. PubMed ID: 9578004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.